{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:59:31Z","timestamp":1790841571995,"version":"4.1.0"},"reference-count":224,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Obesity is becoming an increasing problem worldwide and is often, but not invariably, associated with dyslipidemia. The gut microbiota is increasingly linked to cardiovascular disease, nonalcoholic fatty liver disease, and type 2 diabetes mellitus. However, relatively little focus has been attributed to the role of gut-microbiota-derived metabolites in the development of dyslipidemia and alterations in lipid metabolism. In this review, we discuss current data involved in these processes and point out the therapeutic potentials. We cover the ability of gut microbiota metabolites to alter lipoprotein lipase action, VLDL secretion, and plasma triglyceride levels, and its effects on reverse cholesterol transport, adipocyte dysfunction, and adipose tissue inflammation. Finally, the current intervention strategies for treatment of obesity and dyslipidemia is addressed with emphasis on the role of gut microbiota metabolites and its ability to predict treatment efficacies.<\/jats:p>","DOI":"10.3390\/metabo11080531","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T08:57:14Z","timestamp":1628585834000},"page":"531","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5174-2782","authenticated-orcid":false,"given":"Max S. Z.","family":"Zwartjes","sequence":"first","affiliation":[{"name":"Department of Experimental Vascular Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"},{"name":"Department of Internal Medicine, Spaarne Gasthuis, Spaarnepoort 1, 2134 TM Hoofddorp, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-4399","authenticated-orcid":false,"given":"Victor E. A.","family":"Gerdes","sequence":"additional","affiliation":[{"name":"Department of Experimental Vascular Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"},{"name":"Department of Internal Medicine, Spaarne Gasthuis, Spaarnepoort 1, 2134 TM Hoofddorp, The Netherlands"},{"name":"Department of Internal and Vascular Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[{"name":"Department of Experimental Vascular Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"},{"name":"Department of Internal and Vascular Medicine, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"},{"name":"Department of Internal Medicine, Diabetes Center, Amsterdam University Medical Center, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"ref_1","unstructured":"(2021, January 06). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_2","unstructured":"World Health Organization (2021). Noncommunicable Disease Risk Factors. World Health Statistics 2021: Monitoring Health for the SDGs, Sustainable Development Goals, World Health Organization."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000375143","article-title":"The Global Burden of Obesity and the Challenges of Prevention","volume":"66","author":"Seidell","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mpmed.2014.11.003","article-title":"Medical Consequences of Obesity","volume":"43","author":"Finer","year":"2015","journal-title":"Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-Density Lipoproteins Cause Atherosclerotic Cardiovascular Disease. 1. Evidence from Genetic, Epidemiologic, and Clinical Studies. A Consensus Statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk","volume":"290","author":"Mach","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC201712050","article-title":"Dyslipidemia","volume":"167","author":"Kopin","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular Disease in Europe: Epidemiological Update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1172\/JCI129186","article-title":"Metabolically Healthy Obesity: Facts and Fantasies","volume":"129","author":"Smith","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","article-title":"Gut Microbiota and Cardiovascular Disease","volume":"127","author":"Witkowski","year":"2020","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/17446651.2020.1720511","article-title":"Gut Microbiota: A Promising Target against Cardiometabolic Diseases","volume":"15","author":"Warmbrunn","year":"2020","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1538574416628654","article-title":"Dyslipidemia Part 1\u2014Review of Lipid Metabolism and Vascular Cell Physiology","volume":"50","author":"Helkin","year":"2016","journal-title":"Vasc. Endovasc. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosissup.2010.03.003","article-title":"The Mechanism of the Formation and Secretion of Chylomicrons","volume":"11","author":"Kindel","year":"2010","journal-title":"Atheroscler. Suppl."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3389\/fphys.2019.01604","article-title":"Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization","volume":"10","author":"Xiao","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0022-2275(20)34932-4","article-title":"Hepatic Uptake of Chylomicron Remnants","volume":"38","author":"Cooper","year":"1997","journal-title":"J. Lipid Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1194\/jlr.R067629","article-title":"Short- and Medium-Chain Fatty Acids in Energy Metabolism: The Cellular Perspective","volume":"57","author":"Wojtczak","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De Novo Lipogenesis in the Liver in Health and Disease: More than Just a Shunting Yard for Glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","article-title":"De Novo Fatty-Acid Synthesis and Related Pathways as Molecular Targets for Cancer Therapy","volume":"100","author":"Mashima","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1172\/JCI63967","article-title":"Malonyl-CoA: The Regulator of Fatty Acid Synthesis and Oxidation","volume":"122","author":"Foster","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective Hepatic Insulin Resistance, VLDL Overproduction, and Hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1152\/ajpendo.90920.2008","article-title":"Lipoprotein Lipase: From Gene to Obesity","volume":"297","author":"Wang","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: New Findings Related to Genetics, Biochemistry, and Role in Triglyceride Metabolism","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","article-title":"A Review of the Role of Apolipoprotein C-II in Lipoprotein Metabolism and Cardiovascular Disease","volume":"61","author":"Kei","year":"2012","journal-title":"Metabolism"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI110547","article-title":"Insulin Stimulation of Adipose Tissue Lipoprotein Lipase. Use of the Euglycemic Clamp Technique","volume":"69","author":"Sadur","year":"1982","journal-title":"J. Clin. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma Cholesteryl Ester Transfer Protein","volume":"34","author":"Tall","year":"1993","journal-title":"J. Lipid Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl Ester Transfer Protein","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol Efflux and Atheroprotection: Advancing the Concept of Reverse Cholesterol Transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cmet.2008.03.001","article-title":"HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis","volume":"7","author":"Tall","year":"2008","journal-title":"Cell Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","article-title":"HDL Cholesterol: Reappraisal of Its Clinical Relevance","volume":"106","author":"Kleber","year":"2017","journal-title":"Clin. Res. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacl.2018.04.001","article-title":"Rethinking Reverse Cholesterol Transport and Dysfunctional High-Density Lipoproteins","volume":"12","author":"Gillard","year":"2018","journal-title":"J. Clin. Lipidol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00109-005-0030-4","article-title":"Role of ApoA-I, ABCA1, LCAT, and SR-BI in the Biogenesis of HDL","volume":"84","author":"Zannis","year":"2006","journal-title":"J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","article-title":"Obesity, Adiposity, and Dyslipidemia: A Consensus Statement from the National Lipid Association","volume":"7","author":"Bays","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2008.10.015","article-title":"\u201cSick Fat,\u201d Metabolic Disease, and Atherosclerosis","volume":"122","author":"Bays","year":"2009","journal-title":"Am. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically Healthy Obesity: Epidemiology, Mechanisms, and Clinical Implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3748\/wjg.v22.i2.681","article-title":"New Obesity Classification Criteria as a Tool for Bariatric Surgery Indication","volume":"22","author":"Lorenzo","year":"2016","journal-title":"WJG"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cvr\/cvx106","article-title":"The Molecular Mechanisms of Obesity Paradox","volume":"113","author":"Antonopoulos","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.019","article-title":"Metabolic Health and Weight: Understanding Metabolically Unhealthy Normal Weight or Metabolically Healthy Obese Patients","volume":"65","author":"Mathew","year":"2016","journal-title":"Metabolism"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The Obese without Cardiometabolic Risk Factor Clustering and the Normal Weight with Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes among the US Population (NHANES 1999-2004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1530\/EJE-14-0540","article-title":"Mechanisms in endocrinology: Are Metabolically Healthy Obese Individuals Really Healthy?","volume":"171","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26-Year Follow-up of Participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are Metabolically Healthy Overweight and Obesity Benign Conditions?: A Systematic Review and Meta-Analysis","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.2337\/dc12-1971","article-title":"North West Adelaide Health Study Team Diabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese Phenotype: A Cohort Study","volume":"36","author":"Appleton","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3390\/nu5041218","article-title":"Dyslipidemia in Obesity: Mechanisms and Potential Targets","volume":"5","author":"Klop","year":"2013","journal-title":"Nutrients"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.ijo.0802609","article-title":"Obesity Is the Major Determinant of Elevated C-Reactive Protein in Subjects with the Metabolic Syndrome","volume":"28","author":"Aronson","year":"2004","journal-title":"Int. J. Obes."},{"key":"ref_48","first-page":"2889","article-title":"Disorders of Lipoprotein Metabolism","volume":"Volume 2","author":"Rader","year":"2018","journal-title":"Harrison\u2019s Principles of Internal Medicine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.0954-6820.1969.tb07347.x","article-title":"Plasma Free Fatty Acid Turnover Rate in obesity","volume":"185","author":"Bergman","year":"1969","journal-title":"Acta Med. Scand."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000381224","article-title":"Fatty Acids, Obesity and Insulin Resistance","volume":"8","author":"Arner","year":"2015","journal-title":"Obes. Facts"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The Metabolic Syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The Links between the Gut Microbiome and Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"76","author":"Safari","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_55","first-page":"919","article-title":"Physiological Regulation of Lipoprotein Lipase","volume":"1841","author":"Kersten","year":"2014","journal-title":"Biochim. Et Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"key":"ref_56","first-page":"695","article-title":"Impaired Regulation of Adipose Tissue Lipoprotein Lipase in Obesity","volume":"5","year":"1981","journal-title":"Int. J. Obes."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.ATV.14.7.1129","article-title":"Increased Plasma Cholesteryl Ester Transfer Protein in Obese Subjects. A Possible Mechanism for the Reduction of Serum HDL Cholesterol Levels in Obesity","volume":"14","author":"Arai","year":"1994","journal-title":"Arter. Thromb."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1210\/jc.2004-1325","article-title":"Suppression of Hepatic Cholesteryl Ester Transfer Protein Expression in Obese Humans with the Development of Type 2 Diabetes Mellitus","volume":"90","author":"MacLean","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The Gut Microbiota as an Environmental Factor That Regulates Fat Storage","volume":"101","author":"Ding","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, Stability and Resilience of the Human Gut Microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G., Gasbarrini, A., and Mele, M. (2019). What Is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7.","DOI":"10.3390\/microorganisms7010014"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Leeming, E.R., Johnson, A.J., Spector, T.D., and Le Roy, C.I. (2019). Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients, 11.","DOI":"10.3390\/nu11122862"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"921","DOI":"10.15252\/msb.20167356","article-title":"Transfer of Dysbiotic Gut Microbiota Has Beneficial Effects on Host Liver Metabolism","volume":"13","author":"Nicolas","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3945\/ajcn.110.010132","article-title":"Energy-Balance Studies Reveal Associations between Gut Microbes, Caloric Load, and Nutrient Absorption in Humans","volume":"94","author":"Jumpertz","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut Dysbiosis Is Linked to Hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Human Gut Microbes Associated with Obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes\/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.","DOI":"10.3390\/nu12051474"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","article-title":"Intestinal Microbiota in Cardiovascular Health and Disease","volume":"73","author":"Tang","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","article-title":"The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids","volume":"117","author":"Fu","year":"2015","journal-title":"Circ. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"8127814","DOI":"10.1155\/2017\/8127814","article-title":"Bacterial Community Profile of the Gut Microbiota Differs between Hypercholesterolemic Subjects and Controls","volume":"2017","author":"Rebolledo","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1038\/s41467-019-13721-1","article-title":"Relationship between Gut Microbiota and Circulating Metabolites in Population-Based Cohorts","volume":"10","author":"Vojinovic","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Le Roy, T., L\u00e9cuyer, E., Chassaing, B., Rhimi, M., Lhomme, M., Boudebbouze, S., Ichou, F., Haro Barcel\u00f3, J., Huby, T., and Guerin, M. (2019). The Intestinal Microbiota Regulates Host Cholesterol Homeostasis. BMC Biol., 17.","DOI":"10.1186\/s12915-019-0715-8"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Yun, K.E., Kim, J., Kim, M., Park, E., Kim, H.-L., Chang, Y., Ryu, S., and Kim, H.-N. (2020). Major Lipids, Apolipoproteins, and Alterations of Gut Microbiota. JCM, 9.","DOI":"10.3390\/jcm9051589"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1042\/bj0280820","article-title":"The Formation of Coprosterol in the Intestine1: The Action of Intestinal Bacteria on Cholesterol","volume":"28","author":"Dam","year":"1934","journal-title":"Biochem. J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.femsle.2004.10.042","article-title":"Correlation between Faecal Microbial Community Structure and Cholesterol-to-Coprostanol Conversion in the Human Gut","volume":"242","author":"Veiga","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kriaa, A., Bourgin, M., Mkaouar, H., Jablaoui, A., Akermi, N., Soussou, S., Maguin, E., and Rhimi, M. (2019). Microbial Reduction of Cholesterol to Coprostanol: An Old Concept and New Insights. Catalysts, 9.","DOI":"10.3390\/catal9020167"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chom.2020.05.013","article-title":"Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level","volume":"28","author":"Kenny","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1111\/bph.15440","article-title":"Short-Chain Fatty Acids and Bile Acids in Human Faeces Are Associated with the Intestinal Cholesterol Conversion Status","volume":"178","author":"Matysik","year":"2021","journal-title":"Br. J. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Leenders, J., Grootveld, M., Percival, B., Gibson, M., Casanova, F., and Wilson, P.B. (2020). Benchtop Low-Frequency 60 MHz NMR Analysis of Urine: A Comparative Metabolomics Investigation. Metabolites, 10.","DOI":"10.3390\/metabo10040155"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Percival, B.C., Grootveld, M., Gibson, M., Osman, Y., Molinari, M., Jafari, F., Sahota, T., Martin, M., Casanova, F., and Mather, M.L. (2018). Low-Field, Benchtop NMR Spectroscopy as a Potential Tool for Point-of-Care Diagnostics of Metabolic Conditions: Validation, Protocols and Computational Models. High-Throughput, 8.","DOI":"10.20944\/preprints201810.0089.v2"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tem.2020.11.005","article-title":"Lipoprotein Lipase and Its Regulators: An Unfolding Story","volume":"32","author":"Wu","year":"2021","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.jlr.2021.100068","article-title":"ApoA5 Lowers Triglyceride Levels via Suppression of ANGPTL3\/8-Mediated LPL Inhibition","volume":"62","author":"Chen","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"G1025","DOI":"10.1152\/ajpgi.00293.2012","article-title":"ANGPTL4 Expression Induced by Butyrate and Rosiglitazone in Human Intestinal Epithelial Cells Utilizes Independent Pathways","volume":"304","author":"Korecka","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","article-title":"Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism","volume":"146","author":"Chao","year":"2005","journal-title":"Endocrinology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1074\/jbc.M506519200","article-title":"The Fasting-Induced Adipose Factor\/Angiopoietin-like Protein 4 Is Physically Associated with Lipoproteins and Governs Plasma Lipid Levels and Adiposity","volume":"281","author":"Mandard","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","article-title":"Angiopoietin-like Protein 4 Is a Potent Hyperlipidemia-Inducing Factor in Mice and Inhibitor of Lipoprotein Lipase","volume":"43","author":"Yoshida","year":"2002","journal-title":"J. Lipid Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/ATVBAHA.107.151894","article-title":"Angptl4 Upregulates Cholesterol Synthesis in Liver via Inhibition of LPL- and HL-Dependent Hepatic Cholesterol Uptake","volume":"27","author":"Lichtenstein","year":"2007","journal-title":"ATVB"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1042\/BST0331059","article-title":"Regulation of Lipid Metabolism via Angiopoietin-like Proteins","volume":"33","author":"Kersten","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.108.182147","article-title":"Caloric Restriction and Exercise Increase Plasma ANGPTL4 Levels in Humans via Elevated Free Fatty Acids","volume":"29","author":"Kersten","year":"2009","journal-title":"ATVB"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1017\/S0007114507824081","article-title":"The PPAR\u03b3 Ligand Rosiglitazone Influences Triacylglycerol Metabolism in Non-Obese Males, without Increasing the Transcriptional Activity of PPAR\u03b3 in the Subcutaneous Adipose Tissue","volume":"99","author":"Joosen","year":"2008","journal-title":"Br. J. Nutr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/ATVBAHA.110.212209","article-title":"The Relationship Between Plasma Angiopoietin-like Protein 4 Levels, Angiopoietin-like Protein 4 Genotype, and Coronary Heart Disease Risk","volume":"30","author":"Robciuc","year":"2010","journal-title":"ATVB"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molmet.2013.11.004","article-title":"Angptl4 Serves as an Endogenous Inhibitor of Intestinal Lipid Digestion","volume":"3","author":"Mattijssen","year":"2013","journal-title":"Mol. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/MCB.00858-12","article-title":"Short-Chain Fatty Acids Stimulate Angiopoietin-like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor \u03b3","volume":"33","author":"Alex","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1017\/jns.2016.38","article-title":"A Randomised, Controlled, Crossover Study of the Effect of Diet on Angiopoietin-like Protein 4 (ANGPTL4) through Modification of the Gut Microbiome","volume":"5","author":"Holm","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11883-021-00914-7","article-title":"ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets","volume":"23","author":"Akoumianakis","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-018-0659-y","article-title":"New Insights into ANGPLT3 in Controlling Lipoprotein Metabolism and Risk of Cardiovascular Diseases","volume":"17","author":"Su","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 Deficiency and Protection Against Coronary Artery Disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.bbrc.2009.12.145","article-title":"The Acute Phase Response Stimulates the Expression of Angiopoietin like Protein 4","volume":"391","author":"Lu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11883-017-0665-y","article-title":"Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact","volume":"19","author":"Guardiola","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.numecd.2010.12.003","article-title":"APOA5 Gene Expression in the Human Intestinal Tissue and Its Response to in Vitro Exposure to Fatty Acid and Fibrate","volume":"22","author":"Guardiola","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/gutjnl-2015-311326","article-title":"The Effect of Heritability and Host Genetics on the Gut Microbiota and Metabolic Syndrome","volume":"66","author":"Lim","year":"2017","journal-title":"Gut"},{"key":"ref_104","first-page":"11","article-title":"Nonalcoholic Fatty Liver Disease","volume":"346","author":"Paul","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-16-0513","article-title":"Hepatic Lipid Accumulation: Cause and Consequence of Dysregulated Glucoregulatory Hormones","volume":"234","author":"Geisler","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.2337\/dc11-s249","article-title":"Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis","volume":"34","author":"Perseghin","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","article-title":"A Vicious Circle between Insulin Resistance and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"16","author":"Chen","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut Microbiota and Human NAFLD: Disentangling Microbial Signatures from Metabolic Disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Hoozemans, J., de Brauw, M., Nieuwdorp, M., and Gerdes, V. (2021). Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review. Metabolites, 11.","DOI":"10.3390\/metabo11060353"},{"key":"ref_110","first-page":"31","article-title":"Biological Role of Liver X Receptors","volume":"59","author":"Baranowski","year":"2008","journal-title":"J. Physiol. Pharm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1097-2765(03)00384-8","article-title":"Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism","volume":"12","author":"Castrillo","year":"2003","journal-title":"Mol. Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/ATVBAHA.114.303383","article-title":"Macrophage-Independent Regulation of Reverse Cholesterol Transport by Liver X Receptors","volume":"34","author":"Breevoort","year":"2014","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut Flora Metabolism of Phosphatidylcholine Promotes Cardiovascular Disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal Microbiota Metabolism of L-Carnitine, a Nutrient in Red Meat, Promotes Atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","article-title":"The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance","volume":"10","author":"Warrier","year":"2015","journal-title":"Cell Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"18675","DOI":"10.1038\/s41598-020-75633-1","article-title":"Trimethylamine N-Oxide and the Reverse Cholesterol Transport in Cardiovascular Disease: A Cross-Sectional Study","volume":"10","author":"Bordoni","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCRESAHA.120.317362","article-title":"Gut Microbiota-Associated Activation of TLR5 Induces Apolipoprotein A1 Production in the Liver","volume":"127","author":"Yiu","year":"2020","journal-title":"Circ. Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fphar.2018.00939","article-title":"Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients","volume":"9","author":"Mikov","year":"2018","journal-title":"Front. Pharm."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nchembio.1864","article-title":"A Biosynthetic Pathway for a Prominent Class of Microbiota-Derived Bile Acids","volume":"11","author":"Devlin","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile Acids Lower Triglyceride Levels via a Pathway Involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile Acids Induce the Expression of the Human Peroxisome Proliferator-Activated Receptor Alpha Gene via Activation of the Farnesoid X Receptor","volume":"17","author":"Claudel","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"45685","DOI":"10.1074\/jbc.M404255200","article-title":"Bile Acid Reduces the Secretion of Very Low Density Lipoprotein by Repressing Microsomal Triglyceride Transfer Protein Gene Expression Mediated by Hepatocyte Nuclear Factor-4","volume":"279","author":"Hirokane","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1210\/mend.15.10.0712","article-title":"Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: A Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids","volume":"15","author":"Kast","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted Disruption of the Nuclear Receptor FXR\/BAR Impairs Bile Acid and Lipid Homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/eurheartj\/ehs227","article-title":"Activation of Intestinal Peroxisome Proliferator-Activated Receptor-\u03b1 Increases High-Density Lipoprotein Production","volume":"34","author":"Colin","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X Nuclear Receptor Ligand Obeticholic Acid for Non-Cirrhotic, Non-Alcoholic Steatohepatitis (FLINT): A Multicentre, Randomised, Placebo-Controlled Trial","volume":"385","author":"Loomba","year":"2015","journal-title":"Lancet"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/164_2019_232","article-title":"Nonsteroidal FXR Ligands: Current Status and Clinical Applications","volume":"256","author":"Gege","year":"2019","journal-title":"Handb. Exp. Pharm."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Sayin","year":"2016","journal-title":"Cell Metab."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Portincasa, P., Di Ciaula, A., Garruti, G., Vacca, M., De Angelis, M., and Wang, D.Q.-H. (2020). Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome. Nutrients, 12.","DOI":"10.3390\/nu12123709"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.23032","article-title":"The Membrane-Bound Bile Acid Receptor TGR5 Is Localized in the Epithelium of Human Gallbladders","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1677\/JOE-10-0009","article-title":"Gender-Dependent Effect of Gpbar1 Genetic Deletion on the Metabolic Profiles of Diet-Induced Obese Mice","volume":"205","author":"Vassileva","year":"2010","journal-title":"J. Endocrinol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short Chain Fatty Acids in Human Large Intestine, Portal, Hepatic and Venous Blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The Role of Short-Chain Fatty Acids in the Interplay between Diet, Gut Microbiota, and Host Energy Metabolism","volume":"54","author":"Groen","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fimmu.2016.00028","article-title":"GPR41 and GPR43 in Obesity and Inflammation\u2009-\u2009Protective or Causative?","volume":"7","author":"Ang","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2012.10.007","article-title":"Short Chain Fatty Acids and Their Receptors: New Metabolic Targets","volume":"161","author":"Layden","year":"2013","journal-title":"Transl. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","article-title":"Microbial Regulation of Host Physiology by Short-Chain Fatty Acids","volume":"29","author":"Wells","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1210\/en.2008-0059","article-title":"Activation of G Protein-Coupled Receptor 43 in Adipocytes Leads to Inhibition of Lipolysis and Suppression of Plasma Free Fatty Acids","volume":"149","author":"Ge","year":"2008","journal-title":"Endocrinology"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1210\/en.2005-0545","article-title":"Acetate and Propionate Short Chain Fatty Acids Stimulate Adipogenesis via GPCR43","volume":"146","author":"Hong","year":"2005","journal-title":"Endocrinology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fendo.2017.00372","article-title":"Short-Chain Fatty Acids Differentially Affect Intracellular Lipolysis in a Human White Adipocyte Model","volume":"8","author":"Jocken","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jn\/129.5.942","article-title":"Short-Chain Fatty Acids Suppress Cholesterol Synthesis in Rat Liver and Intestine","volume":"129","author":"Hara","year":"1999","journal-title":"J. Nutr."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3181\/00379727-195-43113","article-title":"Propionate Inhibits Hepatocyte Lipid Synthesis","volume":"195","author":"Wright","year":"1990","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1079\/BJN20061740","article-title":"Dietary Acetic Acid Reduces Serum Cholesterol and Triacylglycerols in Rats Fed a Cholesterol-Rich Diet","volume":"95","author":"Fushimi","year":"2006","journal-title":"Br. J. Nutr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1021\/acs.jafc.7b04666","article-title":"Structure-Specific Effects of Short-Chain Fatty Acids on Plasma Cholesterol Concentration in Male Syrian Hamsters","volume":"65","author":"Zhao","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12944-018-0939-6","article-title":"Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis Is Associated with Bile Acid Metabolism","volume":"17","author":"Ding","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3748\/wjg.v25.i20.2450","article-title":"Trimethylamine N-Oxide Attenuates High-Fat High-Cholesterol Diet-Induced Steatohepatitis by Reducing Hepatic Cholesterol Overload in Rats","volume":"25","author":"Zhao","year":"2019","journal-title":"WJG"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.13038","article-title":"Gut Microbiota in Atherosclerosis: Focus on Trimethylamine N-oxide","volume":"128","author":"Zhu","year":"2020","journal-title":"APMIS"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and Metabolic Health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1007\/s11695-020-04983-6","article-title":"Adipose Morphology: A Critical Factor in Regulation of Human Metabolic Diseases and Adipose Tissue Dysfunction","volume":"30","author":"Liu","year":"2020","journal-title":"Obes. Surg."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"118812","DOI":"10.1016\/j.lfs.2020.118812","article-title":"Adipocyte Hypertrophy Parallels Alterations of Mitochondrial Status in a Cell Model for Adipose Tissue Dysfunction in Obesity","volume":"265","author":"Baldini","year":"2021","journal-title":"Life Sci."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"DeBari, M.K., and Abbott, R.D. (2020). Adipose Tissue Fibrosis: Mechanisms, Models, and Importance. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176030"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1152\/physrev.00034.2017","article-title":"Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity","volume":"98","author":"Hammarstedt","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/j.bpj.2010.10.009","article-title":"Hypertrophy-Driven Adipocyte Death Overwhelms Recruitment under Prolonged Weight Gain","volume":"99","author":"Jo","year":"2010","journal-title":"Biophys. J."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.atherosclerosis.2013.12.023","article-title":"Visceral Adipose Tissue as a Source of Inflammation and Promoter of Atherosclerosis","volume":"233","author":"Alexopoulos","year":"2014","journal-title":"Atherosclerosis"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s001250051560","article-title":"Enlarged Subcutaneous Abdominal Adipocyte Size, but Not Obesity Itself, Predicts Type II Diabetes Independent of Insulin Resistance","volume":"43","author":"Weyer","year":"2000","journal-title":"Diabetologia"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity Induces a Phenotypic Switch in Adipose Tissue Macrophage Polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1210\/jc.2006-1055","article-title":"Relationship between Adipocyte Size and Adipokine Expression and Secretion","volume":"92","author":"Skurk","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","article-title":"Pathogenic Potential of Adipose Tissue and Metabolic Consequences of Adipocyte Hypertrophy and Increased Visceral Adiposity","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1152\/ajpendo.00601.2014","article-title":"Effect of Lipopolysaccharides on Adipogenic Potential and Premature Senescence of Adipocyte Progenitors","volume":"309","author":"Zhao","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"eaav1892","DOI":"10.1126\/scitranslmed.aav1892","article-title":"The Gut Microbiota Regulates White Adipose Tissue Inflammation and Obesity via a Family of MicroRNAs","volume":"11","author":"Virtue","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/msb.2010.46","article-title":"The Endocannabinoid System Links Gut Microbiota to Adipogenesis","volume":"6","author":"Muccioli","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1911572","DOI":"10.1080\/19490976.2021.1911572","article-title":"At the Heart of Microbial Conversations: Endocannabinoids and the Microbiome in Cardiometabolic Risk","volume":"13","author":"Khan","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1194\/jlr.O072629","article-title":"The Metabolic Syndrome in Men Study: A Resource for Studies of Metabolic and Cardiovascular Diseases","volume":"58","author":"Laakso","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Das, S.K., Sharma, N.K., and Zhang, B. (2015). Integrative Network Analysis Reveals Different Pathophysiological Mechanisms of Insulin Resistance among Caucasians and African Americans. BMC Med. Genom., 8.","DOI":"10.1186\/s12920-015-0078-0"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2015-3336","article-title":"Tissue-Specific and Genetic Regulation of Insulin Sensitivity-Associated Transcripts in African Americans","volume":"101","author":"Sharma","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.celrep.2017.05.077","article-title":"The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue","volume":"19","author":"Schugar","year":"2017","journal-title":"Cell Rep."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fendo.2011.00085","article-title":"Uncoupling Protein 1 of Brown Adipocytes, the Only Uncoupler: A Historical Perspective","volume":"2","author":"Ricquier","year":"2011","journal-title":"Front. Endocrin."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/s41467-021-22272-3","article-title":"Brown and Beige Adipose Tissue Regulate Systemic Metabolism through a Metabolite Interorgan Signaling Axis","volume":"12","author":"Whitehead","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of Human Gut Microbiome Correlates with Metabolic Markers","volume":"500","author":"Nielsen","year":"2013","journal-title":"Nature"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose Expression of Tumor Necrosis Factor-Alpha: Direct Role in Obesity-Linked Insulin Resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"107765","DOI":"10.1016\/j.intimp.2021.107765","article-title":"Interleukin-1 in Obesity-Related Low-Grade Inflammation: From Molecular Mechanisms to Therapeutic Strategies","volume":"96","author":"Ghanbari","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/dc11-0631","article-title":"Impact of Physical Inactivity on Adipose Tissue Low-Grade Inflammation in First-Degree Relatives of Type 2 Diabetic Patients","volume":"34","author":"Sonne","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11306-020-01695-x","article-title":"GlycA, a Novel Marker for Low Grade Inflammation, Reflects Gut Microbiome Diversity and Is More Accurate than High Sensitive CRP in Reflecting Metabolomic Profile","volume":"16","author":"Mokkala","year":"2020","journal-title":"Metabolomics"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1753-4887.2011.00414.x","article-title":"Effect of Diet on Adiponectin Levels in Blood","volume":"69","author":"Silva","year":"2011","journal-title":"Nutr. Rev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ijpvm.IJPVM_193_20","article-title":"Adiponectin: Role in Physiology and Pathophysiology","volume":"11","year":"2020","journal-title":"Int. J. Prev. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"585887","DOI":"10.3389\/fendo.2021.585887","article-title":"Leptin and Obesity: Role and Clinical Implication","volume":"12","author":"Obradovic","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/cimm.1999.1490","article-title":"Human Leptin Stimulates Proliferation and Activation of Human Circulating Monocytes","volume":"194","author":"Goberna","year":"1999","journal-title":"Cell. Immunol."},{"key":"ref_181","first-page":"R204","article-title":"IL-1 Beta Mediates Leptin Induction during Inflammation","volume":"274","author":"Faggioni","year":"1998","journal-title":"Am. J. Physiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide Endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/1440-1681.13250","article-title":"Metabolic Endotoxemia and Cardiovascular Disease: A Systematic Review about Potential Roles of Prebiotics and Probiotics","volume":"47","author":"Moludi","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/j.gastro.2012.01.034","article-title":"A High-Fat Diet Is Associated with Endotoxemia That Originates from the Gut","volume":"142","author":"Pendyala","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"15648","DOI":"10.1038\/s41598-018-33928-4","article-title":"Diet Induced Obesity Is Independent of Metabolic Endotoxemia and TLR4 Signalling, but Markedly Increases Hypothalamic Expression of the Acute Phase Protein, SerpinA3N","volume":"8","author":"Dalby","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","article-title":"Lipopolysaccharide Activates an Innate Immune System Response in Human Adipose Tissue in Obesity and Type 2 Diabetes","volume":"292","author":"Creely","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.atherosclerosis.2008.06.018","article-title":"Ethnic and Sex Differences in Circulating Endotoxin Levels: A Novel Marker of Atherosclerotic and Cardiovascular Risk in a British Multi-Ethnic Population","volume":"203","author":"Miller","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00134-006-0432-y","article-title":"Lipoproteins in Inflammation and Sepsis. I. Basic Science","volume":"33","author":"Murch","year":"2007","journal-title":"Intensive Care Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2337\/dc10-2197","article-title":"Bacterial Endotoxin Activity in Human Serum Is Associated with Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation","volume":"34","author":"Lassenius","year":"2011","journal-title":"Dia Care"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1136\/gutjnl-2019-320118","article-title":"Adipose Tissue Derived Bacteria Are Associated with Inflammation in Obesity and Type 2 Diabetes","volume":"69","author":"Massier","year":"2020","journal-title":"Gut"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3945\/ajcn.2010.29673","article-title":"Accruing Evidence on Benefits of Adherence to the Mediterranean Diet on Health: An Updated Systematic Review and Meta-Analysis","volume":"92","author":"Sofi","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"m696","DOI":"10.1136\/bmj.m696","article-title":"Comparison of Dietary Macronutrient Patterns of 14 Popular Named Dietary Programmes for Weight and Cardiovascular Risk Factor Reduction in Adults: Systematic Review and Network Meta-Analysis of Randomised Trials","volume":"369","author":"Ge","year":"2020","journal-title":"BMJ"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2014.01.058","article-title":"Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease","volume":"146","author":"Albenberg","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/gutjnl-2019-320438","article-title":"Mediterranean Diet Intervention in Overweight and Obese Subjects Lowers Plasma Cholesterol and Causes Changes in the Gut Microbiome and Metabolome Independently of Energy Intake","volume":"69","author":"Meslier","year":"2020","journal-title":"Gut"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"100081","DOI":"10.1016\/j.metop.2021.100081","article-title":"Gut Microbiome and Mediterranean Diet in the Context of Obesity. Current Knowledge, Perspectives and Potential Therapeutic Targets","volume":"9","author":"Tsigalou","year":"2021","journal-title":"Metab. Open"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.soard.2019.01.033","article-title":"Altered Gut Microbiome after Bariatric Surgery and Its Association with Metabolic Benefits: A Systematic Review","volume":"15","author":"Davies","year":"2019","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1210\/er.2017-00192","article-title":"Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans","volume":"39","author":"Meijnikman","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.soard.2005.09.009","article-title":"The Effect of Laparoscopic Gastric Bypass Surgery on Dyslipidemia in Severely Obese Patients","volume":"1","author":"Zlabek","year":"2005","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.soard.2017.03.013","article-title":"Different Effects of Bariatric Surgical Procedures on Dyslipidemia: A Registry-Based Analysis","volume":"13","author":"Spivak","year":"2017","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.soard.2016.01.007","article-title":"Lipids and Bariatric Procedures Part 2 of 2: Scientific Statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)","volume":"12","author":"Bays","year":"2016","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s11605-019-04321-x","article-title":"Changes in Gut Microbiota Composition after Bariatric Surgery: A New Balance to Decode","volume":"24","author":"Palmisano","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"ref_202","first-page":"942","article-title":"Gut Microbiota Specific Signatures Are Related to the Successful Rate of Bariatric Surgery","volume":"11","author":"Vidal","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13073-021-00919-6","article-title":"Circulating Bacterial Signature Is Linked to Metabolic Disease and Shifts with Metabolic Alleviation after Bariatric Surgery","volume":"13","author":"Chakaroun","year":"2021","journal-title":"Genome Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the Evidence for the Efficacy and Safety of Statin Therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: Mechanism of Action and Effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J. Cell Mol. Med."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Kaddurah-Daouk, R., Baillie, R.A., Zhu, H., Zeng, Z.-B., Wiest, M.M., Nguyen, U.T., Wojnoonski, K., Watkins, S.M., Trupp, M., and Krauss, R.M. (2011). Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025482"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","article-title":"Statin Therapy Is Associated with Lower Prevalence of Gut Microbiota Dysbiosis","volume":"581","author":"Falony","year":"2020","journal-title":"Nature"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41569-020-0396-6","article-title":"Improved Gut Microbiota Profile in Individuals with Obesity Taking Statins","volume":"17","author":"Lim","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/omi.2017.0130","article-title":"Atorvastatin Treatment Modulates the Gut Microbiota of the Hypercholesterolemic Patients","volume":"22","author":"Khan","year":"2018","journal-title":"OMICS"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40168-017-0312-4","article-title":"Statin Therapy Causes Gut Dysbiosis in Mice through a PXR-Dependent Mechanism","volume":"5","author":"Lareu","year":"2017","journal-title":"Microbiome"},{"key":"ref_211","unstructured":"Pyeritz, R.E., Korf, B.R., and Grody, W.W. (2021). 7\u2014Lipoprotein and Lipid Metabolism. Emery and Rimoin\u2019s Principles and Practice of Medical Genetics and Genomics, Academic Press. [7th ed.]."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1021\/jf900470c","article-title":"Acetic Acid Upregulates the Expression of Genes for Fatty Acid Oxidation Enzymes in Liver to Suppress Body Fat Accumulation","volume":"57","author":"Kondo","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Nihei, N., Okamoto, H., Furune, T., Ikuta, N., Sasaki, K., Rimbach, G., Yoshikawa, Y., and Terao, K. (2018). Dietary \u03b1-Cyclodextrin Modifies Gut Microbiota and Reduces Fat Accumulation in High-Fat-Diet-Fed Obese Mice. Biofactors.","DOI":"10.1002\/biof.1429"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00253-020-10977-2","article-title":"Supplementation of Bacillus Sp. DU-106 Reduces Hypercholesterolemia and Ameliorates Gut Dysbiosis in High-Fat Diet Rats","volume":"105","author":"Huang","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.atherosclerosis.2015.06.030","article-title":"Supplementation with Two Probiotic Strains, Lactobacillus Curvatus HY7601 and Lactobacillus Plantarum KY1032, Reduces Fasting Triglycerides and Enhances Apolipoprotein A-V Levels in Non-Diabetic Subjects with Hypertriglyceridemia","volume":"241","author":"Ahn","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_216","first-page":"CD003177","article-title":"Omega-3 Fatty Acids for the Primary and Secondary Prevention of Cardiovascular Disease","volume":"3","author":"Abdelhamid","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_217","first-page":"dgaa459","article-title":"Omega 3 Improves Both ApoB100-Containing Lipoprotein Turnover and Their Sphingolipid Profile in Hypertriglyceridemia","volume":"105","author":"Zair","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacl.2013.10.003","article-title":"Omega-3 Free Fatty Acids for the Treatment of Severe Hypertriglyceridemia: The EpanoVa fOr Lowering Very High TriglyceridEs (EVOLVE) Trial","volume":"8","author":"Kastelein","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11883-011-0210-3","article-title":"Effects of Eicosapentaenoic Acid versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis","volume":"13","author":"Wei","year":"2011","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1523-1755.2005.00151.x","article-title":"EPA and DHA Reduce LPS-Induced Inflammation Responses in HK-2 Cells: Evidence for a PPAR-\u03b3\u2013Dependent Mechanism","volume":"67","author":"Li","year":"2005","journal-title":"Kidney Int."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/07853890.2018.1511919","article-title":"Effect of Omega-3 Supplements on Plasma Apolipoprotein C-III Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"50","author":"Sahebkar","year":"2018","journal-title":"Ann. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1136\/gutjnl-2017-314968","article-title":"A Randomised Trial of the Effect of Omega-3 Polyunsaturated Fatty Acid Supplements on the Human Intestinal Microbiota","volume":"67","author":"Watson","year":"2018","journal-title":"Gut"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1038\/s41598-017-10382-2","article-title":"Omega-3 Fatty Acids Correlate with Gut Microbiome Diversity and Production of N-Carbamylglutamate in Middle Aged and Elderly Women","volume":"7","author":"Menni","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1863133","article-title":"The Prebiotic Effects of Omega-3 Fatty Acid Supplementation: A Six-Week Randomised Intervention Trial","volume":"13","author":"Vijay","year":"2021","journal-title":"Gut Microbes"}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/11\/8\/531\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:43:37Z","timestamp":1760165017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/11\/8\/531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":224,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["metabo11080531"],"URL":"https:\/\/doi.org\/10.3390\/metabo11080531","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]}}}